
浏览全部资源
扫码关注微信
湖北省中医院光谷院区妇产科/中医肝肾研究及应用湖北省重点实验室,武汉 430070
主治医师,硕士。研究方向:中医妇科。E-mail:196435986@qq.com
主任医师,硕士。研究方向:中医妇科。E-mail:delhv8@163.com
收稿:2025-11-25,
修回:2026-04-08,
录用:2026-04-08,
纸质出版:2026-04-30
移动端阅览
徐静,向英.健脾化痰方调控HMGB1/RAGE通路改善大鼠多囊卵巢综合征的机制研究 [J].中国药房,2026,37(08):1009-1014.
XU Jing,XIANG Ying.Mechanism of Jianpi huatan formula improving polycystic ovary syndrome in rats by regulating the HMGB1/RAGE signaling pathway[J].ZHONGGUO YAOFANG,2026,37(08):1009-1014.
徐静,向英.健脾化痰方调控HMGB1/RAGE通路改善大鼠多囊卵巢综合征的机制研究 [J].中国药房,2026,37(08):1009-1014. DOI: 10.6039/j.issn.1001-0408.2026.08.07.
XU Jing,XIANG Ying.Mechanism of Jianpi huatan formula improving polycystic ovary syndrome in rats by regulating the HMGB1/RAGE signaling pathway[J].ZHONGGUO YAOFANG,2026,37(08):1009-1014. DOI: 10.6039/j.issn.1001-0408.2026.08.07.
目的
2
探究健脾化痰方(JPHTF)调控高迁移率族蛋白B1(HMGB1)/晚期糖基化终末产物受体(RAGE)信号通路对多囊卵巢综合征(PCOS)大鼠的影响。
方法
2
将大鼠随机分为正常(Con)组、PCOS组、JPHTF低剂量(JPHTF-L,5.54 g/kg)组、JPHTF高剂量(JPHTF-H,11.07g/kg)组、JPHTF-H+重组HMGB1蛋白(JPHTF 11.07 g/kg+rHMGB1 8 μg/kg)组和二甲双胍(0.27 g/kg)组,每组12只。除Con组大鼠以1%羧甲基纤维素钠溶液灌胃,同时喂食普通饲料外,其余大鼠通过高脂饮食联合来曲唑制备PCOS模型。造模成功后,各给药组大鼠灌胃/尾静脉注射相应药物,每日1次,连续4周。干预结束24 h后,称量大鼠体重,计算卵巢系数,检测空腹血糖(FBG)和血清中空腹胰岛素(FINS)、促卵泡素(FSH)、黄体生成素(LH)、睾酮(T)、雌二醇(E
2
)水平,计算胰岛素抵抗稳态模型评估指数,以及检测卵巢组织中肿瘤坏死因子α(TNF-α)、白细胞介素18(IL-18)、IL-1β水平和HMGB1、RAGE、磷酸化核因子κB(p-NF-κB)和NF-κB蛋白表达水平,观察卵巢组织形态及囊性卵泡和黄体数量。
结果
2
与PCOS组比较,JPHTF-L组、JPHTF-H组和二甲双胍组大鼠卵巢组织多囊性病变均有不同程度改善;体重,卵巢系数,FBG,囊性卵泡数量,血清中FINS、HOMA-IR、T、LH、LH/FSH水平,卵巢组织中TNF-α、IL-18、IL-1β水平和HMGB1、RAGE蛋白表达水平以及NF-κB蛋白磷酸化水平均显著降低;黄体数量和血清中E
2
、FSH水平均显著升高(
P
<0.05)。与JPHTF-H组比较,JPHTF-H+rHMGB1组大鼠上述指标变化均显著逆转(
P
<0.05)。
结论
2
JPHTF可通过抑制HMGB1/RAGE信号通路来降低PCOS大鼠炎症反应,减轻卵巢损伤,调节激素平衡,改善胰岛素抵抗和卵泡发育。
OBJECTIVE
2
To explore the effects of the Jianpi huatan formula (JPHTF) on polycystic ovary syndrome (PCOS) in rats by regulating the high mobility group box 1 protein (HMGB1)/receptor for advanced glycation end products (RAGE) signaling pathway.
METHODS
2
The rats were randomly divided into the normal (Con) group, the PCOS group, the JPHTF-L group (5.54 g/kg), the JPHTF-H group (11.07 g/kg), the JPHTF-H+rHMGB1 group (11.07 g/kg of JPHTF+8 μg/kg of rHMGB1), and metformin group (0.27 g/kg), with 12 rats in each group. Except for the rats of Con group, which were given 1% sodium carboxymethyl cellulose intragastrically and fed with normal chow, the remaining rats were induced to develop PCOS models by using a high-fat diet combined with letrozole. Af
ter successful modeling, rats in each drug group were administered the corresponding drugs by gavage or tail vein injection once a day for 4 consecutive weeks. 24 h after the intervention, body weight and ovarian coefficient were detected. The levels of fasting blood glucose (FBG), serum levels of fasting insulin (FINS), follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T) and estradiol (E
2
) were detected. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. The levels of tumor necrosis factor-α (TNF-α), interleukin-18 (IL-18) and IL-1β and the protein expressions of HMGB1, RAGE, phosphorylated nuclear factor-κB (p-NF-κB) and NF-κB in the ovarian tissues of rats were detected. The morphology of ovarian tissue was observed, and the numbers of cystic follicles and corpora lutea were counted.
RESULTS
2
Compared with PCOS group, polycystic changes of ovarian tissue in rats showed varying degrees of improvement in the JPHTF-L group, JPHTF-H group, and metformin group; body weight, ovarian coefficient, FBG, the number of cystic follicles, serum levels of FINS, HOMA-IR, T, LH, LH/FSH, the levels of TNF-α, IL-18 and IL-1β and protein expressions of HMGB1 and RAGE in ovarian tissue as well as phosphorylation level of NF-κB protein all significantly decreased; the number of corpora lutea and the serum levels of E
2
and FSH significantly increased (
P
<0.05). Compared with JPHTF-H group, above indexes of rats were reversed significantly in JPHTF-H+rHMGB1 group (
P
<0.05).
CONCLUSIONS
2
JPHTF can reduce the inflammatory response in PCOS rats, mitigate ovarian injury, regulate hormone balance, and improve insulin resistance and follicular development by inhibiting the HMGB1/RAGE signaling pathway.
LIU Z , WANG R H , WANG K H . Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome [J ] . Mol Med , 2025 , 31 ( 1 ): 27 .
WANG J , HUANG Z , CAO Z Y , et al . Loureirin B reduces insulin resistance and chronic inflammation in a rat model of polycystic ovary syndrome by upregulating GPR120 and activating the LKB1/AMPK signaling pathway [J ] . Int J Mol Sci , 2024 , 25 ( 20 ): 11146 .
林安盈 , 杨璐瑜 , 杨正望 , 等 . 健脾化痰方通过调控PPAR信号通路改善PCOS-IR大鼠的机制研究 [J ] . 湖南中医药大学学报 , 2024 , 44 ( 12 ): 2157 - 2163 .
戴月 , 贺冰 , 杨思婕 , 等 . 健脾化痰方治疗脾虚痰湿证多囊卵巢综合征患者调节性T细胞和Th17细胞的影响及模型化评价 [J ] . 中国临床药理学与治疗学 , 2025 , 30 ( 9 ): 1153 - 1164 .
杨璐瑜 , 林安盈 , 杨正望 , 等 . 健脾化痰方通过调控FOXO1/PDK4信号通路干预PCOS-IR大鼠脂代谢的作用机制研究 [J ] . 中国实验动物学报 , 2024 , 32 ( 4 ): 451 - 460 .
何俊见 , 刘洪祥 , 霍佳宁 , 等 . 高迁移率族蛋白-1和晚期糖基化终末产物受体在多囊卵巢综合征大鼠模型中的表达 [J ] . 中国计划生育和妇产科 , 2019 , 11 ( 6 ): 20 - 23 .
潘静 , 热汗古丽·库尔班 , 吐松古·艾买尔 , 等 . LncRNA LUCAT1调控miR-375/HMGB1轴对多囊卵巢综合征大鼠胰岛素抵抗的机制研究 [J ] . 现代生物医学进展 , 2024 , 24 ( 8 ): 1439 - 1443 .
巫园园 , 朱惠卿 , 刘春明 , 等 . 花红颗粒调节PI3K/Akt通路对多囊卵巢综合征伴胰岛素抵抗大鼠的作用机制研究 [J ] . 中药新药与临床药理 , 2022 , 33 ( 9 ): 1149 - 1155 .
董双千 , 汤怡倩 , 徐浩田 , 等 . 启宫丸对多囊卵巢综合征-胰岛素抵抗大鼠AdipoR/AMPK信号通路的影响 [J ] . 中成药 , 2025 , 47 ( 2 ): 584 - 589 .
YUAN X , YANG J S , SUN D L , et al . 1,25-Dihydroxyvitamin D inhibits hepatic diacyglycerol accumulation and ameliorates metabolic dysfunction in polycystic ovary syndrome rat models [J ] . Front Pharmacol , 2023 , 14 : 1077014 .
ZHAO F Z , CUI W , FANG C M , et al . Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats [J ] . J Ovarian Res , 2024 , 17 ( 1 ): 229 .
KHOSROWPOUR Z , FAHIMI S , JAFARI F , et al . Beneficial effects of Teucrium polium hydroalcoholic extract on letrozole-induced polycystic ovary syndrome in rat model [J ] . Obstet Gynecol Sci , 2023 , 66 ( 2 ): 107 - 117 .
LI M H , GAO S , KANG M C , et al . Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway [J ] . Phytomedicine , 2023 , 117 : 154908 .
李岚 , 杨正望 , 余曦明 . 健脾化痰方对脾虚痰湿证多囊卵巢综合征胰岛素抵抗患者子宫内膜容受性、抗苗勒管激素的影响 [J ] . 中国性科学 , 2023 , 32 ( 4 ): 103 - 107 .
林安盈 , 杨璐瑜 , 孔倩 , 等 . 健脾化痰方通过PI3K/AKT/mTOR和PI3K/AKT/GLUT4通路干预PCOS-IR大鼠的作用机制研究 [J ] . 时珍国医国药 , 2023 , 34 ( 10 ): 2362 - 2365 .
刘金玲 . 健脾化痰方治疗脾虚痰湿型PCOS的临床观察 [D ] . 哈尔滨 : 黑龙江中医药大学 , 2023 .
SINGH H , AGRAWAL D K . Therapeutic potential of targeting the HMGB1/RAGE axis in inflammatory diseases [J ] . Molecules , 2022 , 27 ( 21 ): 7311 - 7320 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621